1. Ferraccioli GF, Bambara LM, Ferraris M, Perpignano G, Cattaneo R, Porzio F, Accardo S, Mattara L, Zoppini A, Benucci M, Ostuni PA, Pasero G (1997) Effects of cyclosporin on joint damage in rheumatoid arthritis. The Italian Rheumatologists Study Group on Rheumatoid Arthritis. Clin Exp Rheumatol 15:S83–S89
2. Amor KT, Ryan C, Menter A (2010) The use of cyclosporine in dermatology: part I. J Am Acad Dermatol 63:925–946
3. Zhang X, Cui J, Qiu M-C, Li D-Q, Zhang P, Zhang J-S (2008) The effects of cyclosporine A on immunoglobulins deposition in retina of streptozotocin-induced diabetic rats. Zhonghua Nei Ke Za Zhi 47:125–128
4. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O’Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG (2012) 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64:625–639
5. Dougados M, Amor B (1987) Cyclosporin A in rheumatoid arthritis: preliminary clinical results of an open trial. Arthritis Rheum 30:83–87